Emerging evidence suggests a common pathological pathway linking PD and T2DM, involving factors such as altered insulin signaling, insulin resistance, oxidative stress, mitochondrial dysfunction, neuroinflammation, and protein accumulation [13,14,15,16]. The gene discussed is INS; the disease is Parkinson disease.